Janux Therapeutics, Inc. — DEFA14A Filings
5 DEFA14A filings on record
This page lists all DEFA14A filings submitted to the SEC by Janux Therapeutics, Inc. (JANX), sorted by most recent first. Each row links to the full filing on EdgarLookup. Janux Therapeutics, Inc. has filed 5 DEFA14A documents with the SEC since 2020. To view all SEC filings by Janux Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
144/A
3
3/A
4
4/A
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
EFFECT
FWP
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEFA14A | DEFA14A | 0000950170-25-058809 | Apr 25, 2025 | — |
| DEFA14A | DEFA14A | 0001193125-24-162678 | Jun 17, 2024 | — |
| DEFA14A | DEFA14A | 0000950170-24-049893 | Apr 29, 2024 | — |
| DEFA14A | DEFA14A | 0000950170-23-015925 | Apr 28, 2023 | — |
| DEFA14A | DEFA14A | 0000950170-22-006746 | Apr 29, 2022 | — |